Hexamethylene bisacetamide (BioDeep_00001874365)
代谢物信息卡片
Hexamethylene bisacetamide
化学式: C10H20N2O2 (200.1525)
中文名称: N,N-六亚甲基双乙酰胺
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC(=O)NCCCCCCNC(=O)C
InChI: InChI=1S/C10H20N2O2/c1-9(13)11-7-5-3-4-6-8-12-10(2)14/h3-8H2,1-2H3,(H,11,13)(H,12,14)
描述信息
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer
D006401 - Hematologic Agents > D006397 - Hematinics
D000970 - Antineoplastic Agents
同义名列表
1 个代谢物同义名
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
| 亚细胞结构定位 | 关联基因列表 |
|---|
文献列表
- Daniel J Warner, Hongming Chen, Louis-David Cantin, J Gerry Kenna, Simone Stahl, Clare L Walker, Tobias Noeske. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Drug metabolism and disposition: the biological fate of chemicals.
2012 Dec; 40(12):2332-41. doi:
10.1124/dmd.112.047068. [PMID: 22961681] - Inna Freikman, Eitan Fibach. Distribution and shedding of the membrane phosphatidylserine during maturation and aging of erythroid cells.
Biochimica et biophysica acta.
2011 Dec; 1808(12):2773-80. doi:
10.1016/j.bbamem.2011.08.014. [PMID: 21871434] - Kerri M Smith, Wannarasmi Ketchart, Xiang Zhou, Monica M Montano, Yan Xu. Determination of hexamethylene bisacetamide, an antineoplastic compound, in mouse and human plasma by LC-MS/MS.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2011 Aug; 879(23):2206-12. doi:
10.1016/j.jchromb.2011.06.002. [PMID: 21723208] - Sheila L Flack, Louise M Ball, Leena A Nylander-French. Occupational exposure to HDI: progress and challenges in biomarker analysis.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2010 Oct; 878(27):2635-42. doi:
10.1016/j.jchromb.2010.01.012. [PMID: 20176515] - Laurence Colin, Carine Van Lint. Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.
Retrovirology.
2009 Dec; 6(?):111. doi:
10.1186/1742-4690-6-111. [PMID: 19961595] - S Naito, S Obayashi, T Sumi, S Iwai, M Nakazawa, K Ikuta, Y Yura. Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide.
Cancer gene therapy.
2006 Aug; 13(8):780-91. doi:
10.1038/sj.cgt.7700957. [PMID: 16645620] - C Cellai, A Laurenzana, A M Vannucchi, R Caporale, M Paglierani, S Di Lollo, A Pancrazzi, F Paoletti. Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086.
British journal of cancer.
2006 Jun; 94(11):1637-42. doi:
10.1038/sj.bjc.6603156. [PMID: 16721373] - Pablo V Escriba, P Morales, Ann Smith. Membrane phospholipid reorganization differentially regulates metallothionein and heme oxygenase by heme-hemopexin.
DNA and cell biology.
2002 Apr; 21(4):355-64. doi:
10.1089/104454902753759762. [PMID: 12042074] - Jonathan S Draper, Christine Pigott, James A Thomson, Peter W Andrews. Surface antigens of human embryonic stem cells: changes upon differentiation in culture.
Journal of anatomy.
2002 Mar; 200(Pt 3):249-58. doi:
10.1046/j.1469-7580.2002.00030.x. [PMID: 12033729] - D S Wang, X D Shi, Y Y Liang. [Regulation of Chinese medicine bailong and hexamethylene bisacetamide on cyclin dependent kinase inhibitor P16 genes in human cancer cell].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
2001 Oct; 21(10):763-6. doi:
". [PMID: 12575612] - T Ogawa, T Hayashi, N Yorioka, S Kyoizumi, J E Trosko. Hexamethylene bisacetamide protects peritoneal mesothelial cells from glucose.
Kidney international.
2001 Sep; 60(3):996-1008. doi:
10.1046/j.1523-1755.2001.060003996.x. [PMID: 11532094] - B Y Li, Y Y Liang, D S Wang. [Regulative effects of bailong and Hexamethylene bisacetamide on growth and phenotype of human gastric cancer cells in cell cycle].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
2001 May; 21(5):354-8. doi:
". [PMID: 12577421] - B Y Li, Y Y Liang, D S Wang. [Study on common character of regulative molecular mechanism of Chinese drug bailong and hexamethylen bisacetamide in human cancer cell cycle and their oncogene and tumor suppressor gene expression].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
2001 Apr; 21(4):286-90. doi:
". [PMID: 12577360] - R Herrero, M R Moncelli, R Guidelli, M Carlà, A Arcangeli, M Olivotto. Hybrid polar compounds produce a positive shift in the surface dipole potential of self-assembled phospholipid monolayers.
Biochimica et biophysica acta.
2000 Jun; 1466(1-2):278-88. doi:
10.1016/s0005-2736(00)00181-4. [PMID: 10825449] - A A Ruefli, M J Smyth, R W Johnstone. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance.
Blood.
2000 Apr; 95(7):2378-85. doi:
NULL. [PMID: 10733510] - T Yamashita, H Wakao, A Miyajima, S Asano. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line.
Cancer research.
1998 Feb; 58(3):556-61. doi:
NULL. [PMID: 9458105] - D S Siegel, X Zhang, R Feinman, T Teitz, A Zelenetz, V M Richon, R A Rifkind, P A Marks, J Michaeli. Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells.
Proceedings of the National Academy of Sciences of the United States of America.
1998 Jan; 95(1):162-6. doi:
10.1073/pnas.95.1.162. [PMID: 9419346] - M Taimi, Z X Chen, T R Breitman. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
Oncology research.
1998; 10(2):75-84. doi:
. [PMID: 9666515] - F Ling, L Fan, L Zhao, L Chen. [Analysis of hexamethylene bisacetamide in biological fluids and tissues by RP-HPLC].
Se pu = Chinese journal of chromatography.
1997 Sep; 15(5):458-9. doi:
NULL. [PMID: 15739509] - S Ishikawa, S Hori, M Kusuhara, Y Kanai, S Handa, K Yamaguchi, Y Hosoda, S Ogawa. Differentiating agent, hexamethylene bisacetamide, inhibits neointimal formation after vascular injury.
Coronary artery disease.
1997 Jan; 8(1):28-32. doi:
NULL. [PMID: 9101119] - Y Yura, H Tsujimoto, J Kusaka, H Yoshida, M Sato. Hexamethylene bisacetamide as a chemopreventive agent in hamster cheek pouch tumorigenesis.
European journal of cancer. Part B, Oral oncology.
1996 Jul; 32B(4):246-50. doi:
10.1016/0964-1955(95)00094-1. [PMID: 8776421] - T Kojima, T Mitaka, T Mizuguchi, Y Mochizuki. Effects of oxygen radical scavengers on connexins 32 and 26 expression in primary cultures of adult rat hepatocytes.
Carcinogenesis.
1996 Mar; 17(3):537-44. doi:
10.1093/carcin/17.3.537. [PMID: 8631141] - Z Zhang, Y Batres, S Y Ying. Activin A inhibits growth and hexamethylene bisacetamide-induced differentiation in human retinoblastoma Y-79 cells.
Anticancer research.
1996 Jan; 16(1):269-72. doi:
NULL. [PMID: 8615619] - S Herwig, Q Su, W Zhang, Y Ma, P Tempst. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
Blood.
1996 Jan; 87(1):350-64. doi:
NULL. [PMID: 8547662] - A Pessino, M Passalacqua, B Sparatore, M Patrone, E Melloni, S Pontremoli. Antisense oligodeoxynucleotide inhibition of delta protein kinase C expression accelerates induced differentiation of murine erythroleukaemia cells.
The Biochemical journal.
1995 Dec; 312 ( Pt 2)(?):549-54. doi:
10.1042/bj3120549. [PMID: 8526869] - J Thyberg, A Hultgårdh-Nilsson, B Kallin. Inhibitors of ADP-ribosylation suppress phenotypic modulation and proliferation of smooth muscle cells cultured from rat aorta.
Differentiation; research in biological diversity.
1995 Nov; 59(4):243-52. doi:
10.1046/j.1432-0436.1995.5940243.x. [PMID: 8575646] - F Paoletti, A M Vannucchi, A Mocali, R Caporale, S A Burstein. Identification and conditions for selective expression of megakaryocytic markers in Friend erythroleukemia cells.
Blood.
1995 Oct; 86(7):2624-31. doi:
NULL. [PMID: 7670106] - P R Kemp, J C Metcalfe, D J Grainger. ID--a dominant negative regulator of skeletal muscle differentiation--is not involved in maturation or differentiation of vascular smooth muscle cells.
FEBS letters.
1995 Jul; 368(1):81-6. doi:
10.1016/0014-5793(95)00605-9. [PMID: 7615094] - P Pietrangeli, C Steinkühler, L Marcocci, J Z Pedersen, B Mondovì, I Mavelli. Enhancement of daunomycin toxicity by the differentiation inducer hexamethylene bisacetamide in erythroleukemia cells.
Biochimica et biophysica acta.
1994 Oct; 1224(1):89-98. doi:
10.1016/0167-4889(94)90116-3. [PMID: 7948045] - M Comelli, G Lippe, I Mavelli. Differentiation potentiates oxidant injury to mitochondria by hydrogen peroxide in Friend's erythroleukemia cells.
FEBS letters.
1994 Sep; 352(1):71-5. doi:
10.1016/0014-5793(94)00882-5. [PMID: 7925947] - X B Wang, Y Huang, P R Gascoyne, F F Becker, R Hölzel, R Pethig. Changes in Friend murine erythroleukaemia cell membranes during induced differentiation determined by electrorotation.
Biochimica et biophysica acta.
1994 Aug; 1193(2):330-44. doi:
10.1016/0005-2736(94)90170-8. [PMID: 8054355] - P W Andrews, I Damjanov, J Berends, S Kumpf, V Zappavigna, F Mavilio, K Sampath. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
Laboratory investigation; a journal of technical methods and pathology.
1994 Aug; 71(2):243-51. doi:
NULL. [PMID: 7521445] - P Kiefer, M Bacher, K H Pflüger. Relationship of calcitonin mRNA expression to the differentiation state of HL 60 cells.
Leukemia & lymphoma.
1994 May; 13(5-6):501-7. doi:
10.3109/10428199409049641. [PMID: 7520792] - S F Yet, C T Kong, H Peng, J E Lever. Regulation of Na+/glucose cotransporter (SGLT1) mRNA in LLC-PK1 cells.
Journal of cellular physiology.
1994 Mar; 158(3):506-12. doi:
10.1002/jcp.1041580315. [PMID: 7510295] - J S Roth, J A Kelley, H G Chun, F T Ward. Simultaneous measurement of the cell-differentiating agent hexamethylene bisacetamide and its metabolites by gas chromatography.
Journal of chromatography.
1994 Feb; 652(2):149-59. doi:
10.1016/0378-4347(93)e0395-7. [PMID: 8006099] - Y X Zhao, X Y He, M Jiang, J W Xie, T Q Xie, L Q Ren. [Determination of hexamethylene bisacetamide in plasma by high performance liquid chromatography].
Yao xue xue bao = Acta pharmaceutica Sinica.
1994; 29(7):550-2. doi:
NULL. [PMID: 7976361] - H Peng, J E Lever. Polyamine regulation of Na+/glucose symporter expression in LLC-PK1 cells.
Journal of cellular physiology.
1993 Feb; 154(2):238-47. doi:
10.1002/jcp.1041540205. [PMID: 8381124] - T Murate, K Yamashita, H Ohashi, Y Kagami, K Tsushita, T Kinoshita, T Hotta, H Saito, S Yoshida, K J Mori. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Experimental hematology.
1993 Jan; 21(1):169-76. doi:
NULL. [PMID: 8417953] - K Naeem, D D Caywood, S M Goyal, R E Werdin, M P Murtaugh. Persistence of bovid herpesvirus-4 in experimentally inoculated pregnant rabbits.
The new microbiologica.
1993 Jan; 16(1):87-93. doi:
NULL. [PMID: 8385734] - M Andreeff, R Stone, J Michaeli, C W Young, W P Tong, H Sogoloff, T Ervin, D Kufe, R A Rifkind, P A Marks. Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent.
Blood.
1992 Nov; 80(10):2604-9. doi:
NULL. [PMID: 1421378] - F Mencherini, S Khochbin, A Chabanas, J J Lawrence. Seric factors influence cell cycle modifications during commitment of murine erythroleukemia cells to differentiation.
Cytometry.
1992; 13(5):518-24. doi:
10.1002/cyto.990130511. [PMID: 1633731] - B A Conley, M J Egorin, V Sinibaldi, G Sewack, C Kloc, L Roberts, E G Zuhowski, A Forrest, D A Van Echo. Approaches to optimal dosing of hexamethylene bisacetamide.
Cancer chemotherapy and pharmacology.
1992; 31(1):37-45. doi:
10.1007/bf00695992. [PMID: 1333894] - F T Ward, J A Kelley, J S Roth, F A Lombardo, R B Weiss, B Leyland-Jones, H G Chun. Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube.
Cancer research.
1991 Apr; 51(7):1803-10. doi:
NULL. [PMID: 2004365] - S Capitani, A M Billi, V Bertagnolo, M Previati, M Mazzoni, L M Neri, F A Manzoli. Inositol lipids in Friend erythroleukemia cells: evidence for changes in nuclear metabolism after differentiation.
Cell biochemistry and function.
1991 Apr; 9(2):135-45. doi:
10.1002/cbf.290090211. [PMID: 1657433] - B A Conley, G F Sewack, M J Egorin, B Subramanyam, J G Page, C K Grieshaber. The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide.
Cancer chemotherapy and pharmacology.
1991; 28(1):33-8. doi:
10.1007/bf00684953. [PMID: 2040031] - N F Guilbaud, N Gas, M A Dupont, A Valette. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells.
Journal of cellular physiology.
1990 Oct; 145(1):162-72. doi:
10.1002/jcp.1041450122. [PMID: 2211839] - T R Breitman, R Y He. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Cancer research.
1990 Oct; 50(19):6268-73. doi:
NULL. [PMID: 2400989] - S Capitani, M Mazzoni, V Bertagnolo, M Previati, A Daddona, D Ricci, F A Manzoli. Nuclear inositol lipids in Friend erythroleukemia cells. Changes related to differentiation induced by hexamethylenebisacetamide.
Cell biology international reports.
1990 Sep; 14(9):783-95. doi:
10.1016/0309-1651(90)90005-j. [PMID: 2177679] - F Salamino, M Passalacqua, M Patrone, P L Viotti, B Sparatore. Murine erythroleukemia cell differentiation: possible involvement of a calcium dependent neutral proteinase.
Biochemistry international.
1990 Aug; 21(5):901-8. doi:
NULL. [PMID: 2256952] - P Schroy, J Rifkin, R J Coffey, S Winawer, E Friedman. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide.
Cancer research.
1990 Jan; 50(2):261-5. doi:
NULL. [PMID: 2295065] - H T Hassan, J K Rees. Effect of AML serum on normal human myeloid differentiation and hexamethylene bisacetamide-induced granulocytic differentiation of the human HL-60 promyelocytic leukaemic cell line.
Folia haematologica (Leipzig, Germany : 1928).
1990; 117(1):151-9. doi:
NULL. [PMID: 1695170] - H Tawhid, J Rees. Triple combination of retinoic acid + 6-thioguanine + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture.
Leukemia research.
1990; 14(2):109-17. doi:
10.1016/0145-2126(90)90039-c. [PMID: 2314112] - H T Hassan, J K Rees. Triple combination of retinoic acid + low concentration of cytosine arabinoside + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture.
Hematological oncology.
1989 Nov; 7(6):429-40. doi:
10.1002/hon.2900070606. [PMID: 2807181] - B Subramanyam, P S Callery, M J Egorin, S W Snyder, B A Conley. An active, aldehydic metabolite of the cell-differentiating agent hexamethylene bisacetamide.
Drug metabolism and disposition: the biological fate of chemicals.
1989 Jul; 17(4):398-401. doi:
NULL. [PMID: 2571479] - B A Conley, A Forrest, M J Egorin, E G Zuhowski, V Sinibaldi, D A Van Echo. Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580).
Cancer research.
1989 Jun; 49(12):3436-40. doi:
NULL. [PMID: 2720696] - M L Taub, J A Syracuse, J W Cai, P Fiorella, J R Subjeck. Glucose deprivation results in the induction of glucose-regulated proteins and domes in MDCK monolayers in hormonally defined serum-free medium.
Experimental cell research.
1989 May; 182(1):105-13. doi:
10.1016/0014-4827(89)90283-8. [PMID: 2714397] - J E Lever. Chemical inducers of differentiation in a long-term renal cell line.
Environmental health perspectives.
1989 Mar; 80(?):173-80. doi:
10.1289/ehp.8980173. [PMID: 2647478] - C W Young, M P Fanucchi, T Declan Walsh, L Baltzer, S Yaldaei, Y W Stevens, C Gordon, W Tong, R A Rifkind, P A Marks. Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.
Cancer research.
1988 Dec; 48(24 Pt 1):7304-9. doi:
NULL. [PMID: 3191501] - A Fallani, A Arcangeli, S Ruggieri. Characteristics of ether-linked glycerophospholipids in Friend erythroleukaemia cells differentiated by dimethyl sulphoxide or hexamethylenebisacetamide and in non-inducible clones treated with the inducers.
The Biochemical journal.
1988 Oct; 255(2):731-5. doi:
". [PMID: 3202842] - P C Schroy, K Carnright, S J Winawer, E A Friedman. Heterogeneous responses of human colon carcinomas to hexamethylene bisacetamide.
Cancer research.
1988 Oct; 48(19):5487-94. doi:
NULL. [PMID: 2458179] - S W Snyder, M J Egorin, L A Geelhaar, A W Hamburger, P S Callery. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
Cancer research.
1988 Jul; 48(13):3613-6. doi:
NULL. [PMID: 3163938] - A Fallani, A Arcangeli, S Ruggieri. Lipid characteristics of Friend erythroleukaemia cells differentiated by dimethyl sulphoxide or hexamethylenebisacetamide, and of non-inducible clones treated with the inducers.
The Biochemical journal.
1988 Jun; 252(3):917-20. doi:
10.1042/bj2520917. [PMID: 3421933] - M J Egorin, S W Snyder, A S Cohen, E G Zuhowski, B Subramanyam, P S Callery. Metabolism of hexamethylene bisacetamide and its metabolites in leukemic cells.
Cancer research.
1988 Apr; 48(7):1712-6. doi:
NULL. [PMID: 3162401] - B A Conley, M J Egorin, E G Zuhowski, V J Sinibaldi, D E Peterson. Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions.
Cancer chemotherapy and pharmacology.
1988; 22(1):65-8. doi:
10.1007/bf00254184. [PMID: 3396146] - B A Conley, P S Callery, M J Egorin, B Subramanyam, L A Geelhaar, S S Pan. Involvement of monoamine oxidase and diamine oxidase in the metabolism of the cell differentiating agent hexamethylene bisacetamide (HMBA).
Life sciences.
1988; 43(9):793-800. doi:
10.1016/0024-3205(88)90180-4. [PMID: 3137409] - M J Egorin, E G Zuhowski, A S Cohen, L A Geelhaar, P S Callery, D A Van Echo. Plasma pharmacokinetics and urinary excretion of hexamethylene bisacetamide metabolites.
Cancer research.
1987 Nov; 47(22):6142-6. doi:
NULL. [PMID: 3664514] - E K Rowinsky, D S Ettinger, W P McGuire, D A Noe, L B Grochow, R C Donehower. Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological study.
Cancer research.
1987 Nov; 47(21):5788-95. doi:
NULL. [PMID: 3664482] - A Arcangeli, L Ricupero, M Olivotto. Commitment to differentiation of murine erythroleukemia cells involves a modulated plasma membrane depolarization through Ca2+-activated K+ channels.
Journal of cellular physiology.
1987 Sep; 132(3):387-400. doi:
10.1002/jcp.1041320302. [PMID: 2443510] - Y Yoneyama, J E Lever. Apical trehalase expression associated with cell patterning after inducer treatment of LLC-PK1 monolayers.
Journal of cellular physiology.
1987 Jun; 131(3):330-41. doi:
10.1002/jcp.1041310305. [PMID: 3298285] - M J Egorin, E G Zuhowski, M S Nayar, P S Callery. Gas chromatographic analysis of metabolites of the cell differentiating agent hexamethylene bisacetamide.
Journal of chromatography.
1987 Mar; 415(1):148-55. doi:
10.1016/s0378-4347(00)83203-x. [PMID: 3584350] - M J Egorin, L M Sigman, D A Van Echo, A Forrest, M Y Whitacre, J Aisner. Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.
Cancer research.
1987 Jan; 47(2):617-23. doi:
NULL. [PMID: 3791246] - A Fallani, A Arcangeli, S Ruggieri. Lipid changes associated with erythroid differentiation of Friend erythroleukemia cells.
Toxicologic pathology.
1987; 15(2):170-7. doi:
10.1177/019262338701500207. [PMID: 3475757] - E K Rowinsky, D S Ettinger, L B Grochow, R B Brundrett, A E Cates, R C Donehower. Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1986 Dec; 4(12):1835-44. doi:
10.1200/jco.1986.4.12.1835. [PMID: 3783206] - P S Callery, M J Egorin, L A Geelhaar, M S Nayar. Identification of metabolites of the cell-differentiating agent hexamethylene bisacetamide in humans.
Cancer research.
1986 Oct; 46(10):4900-3. doi:
NULL. [PMID: 3756851] - E Fibach, N Nahas, H Giloh, S Gatt. Uptake of fluorescent fatty acids by erythroleukemia cells. Effect of differentiation.
Experimental cell research.
1986 Sep; 166(1):220-8. doi:
10.1016/0014-4827(86)90521-5. [PMID: 3462004] - J E Lever. Expression of differentiated functions in kidney epithelial cell lines.
Mineral and electrolyte metabolism.
1986; 12(1):14-9. doi:
NULL. [PMID: 2421145] - B G Kennedy, J E Lever. Transport by the (Na+,K+) ATPase: modulation by differentiation inducers and inhibition of protein synthesis in the MDCK kidney epithelial cell line.
Journal of cellular physiology.
1985 Jun; 123(3):410-6. doi:
10.1002/jcp.1041230317. [PMID: 2580848] - K Amsler, J S Cook. Linear relationship of phlorizin-binding capacity and hexose uptake during differentiation in a clone of LLC-PK1 cells.
Journal of cellular physiology.
1985 Feb; 122(2):254-8. doi:
10.1002/jcp.1041220214. [PMID: 2578475] - C L Litterst, J S Roth, J A Kelley. Distribution, elimination, metabolism and bioavailability of hexamethylenebisacetamide in rats.
Investigational new drugs.
1985; 3(3):263-72. doi:
10.1007/bf00179430. [PMID: 4066220] - Y Yoneyama, J E Lever. Induction of microvillar hydrolase activities by cell density and exogenous differentiation inducers in an established kidney epithelial cell line (LLC-PK1).
Journal of cellular physiology.
1984 Oct; 121(1):64-73. doi:
10.1002/jcp.1041210109. [PMID: 6090480] - B G Kennedy, J E Lever. Regulation of Na+,K+-ATPase activity in MDCK kidney epithelial cell cultures: role of growth state, cyclic AMP, and chemical inducers of dome formation and differentiation.
Journal of cellular physiology.
1984 Oct; 121(1):51-63. doi:
10.1002/jcp.1041210108. [PMID: 6090479] - J J Dibner, C D Knight. Conversion of 2-hydroxy-4-(methylthio)butanoic acid to L-methionine in the chick: a stereospecific pathway.
The Journal of nutrition.
1984 Sep; 114(9):1716-23. doi:
10.1093/jn/114.9.1716. [PMID: 6381670] - J L Ryan, P K Bondy, L Gobran, Z N Canellakis. Acetylated diamines inhibit endotoxin-induced lymphocyte activation.
Journal of immunology (Baltimore, Md. : 1950).
1984 Apr; 132(4):1888-91. doi:
NULL. [PMID: 6366053] - C Billard, M Billard, Z Mishal. Effects of differentiation inducers on diphenylhexatriene fluorescence polarization in intracytoplasmic and plasma membranes from Friend erythroleukemia cells.
Biochemical and biophysical research communications.
1983 Nov; 117(1):294-8. doi:
10.1016/0006-291x(83)91574-7. [PMID: 6661226] - R Gambari. [Commitment to erythroid differentiation and globin gene expression in the absence of heme accumulation in Friend leukemia cells].
Bollettino della Societa italiana di biologia sperimentale.
1983 May; 59(5):631-7. doi:
NULL. [PMID: 6882562] - K Amsler, C Shaffer, J S Cook. Growth-dependent AIB and meAIB uptake in LLC-PK1 cells: effects of differentiation inducers and of TPA.
Journal of cellular physiology.
1983 Feb; 114(2):184-90. doi:
10.1002/jcp.1041140207. [PMID: 6185510] - S R Thomas, S G Schultz, J E Lever. Stimulation of dome formation in MDCK kidney epithelial cultures by inducers of differentiation: dissociation from effects on transepithelial resistance and cyclic AMP levels.
Journal of cellular physiology.
1982 Dec; 113(3):427-32. doi:
10.1002/jcp.1041130311. [PMID: 6294127] - K Amsler, J S Cook. Development of Na+-dependent hexose transport in a cultured line of porcine kidney cells.
The American journal of physiology.
1982 Jan; 242(1):C94-101. doi:
10.1152/ajpcell.1982.242.1.c94. [PMID: 6277200] - Y Gazitt. Comparative study of two groups of inducers of Friend erythroleukemia cell differentiation in a chemically defined medium.
Cancer research.
1981 Mar; 41(3):1184-6. doi:
NULL. [PMID: 6936075] - R C Reuben. Studies on the mechanism of action of hexamethylene bisacetamide, a potent inducer of erythroleukemic differentiation.
Biochimica et biophysica acta.
1979 Dec; 588(3):310-21. doi:
10.1016/0304-4165(79)90339-8. [PMID: 292456] - J E Lever. Inducers of mammalian cell differentiation stimulate dome formation in a differentiated kidney epithelial cell line (MDCK).
Proceedings of the National Academy of Sciences of the United States of America.
1979 Mar; 76(3):1323-7. doi:
10.1073/pnas.76.3.1323. [PMID: 220613] - H Yamasaki, E Fibach, U Nudel, I B Weinstein, R A Rifkind, P A Marks. Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.
Proceedings of the National Academy of Sciences of the United States of America.
1977 Aug; 74(8):3451-5. doi:
10.1073/pnas.74.8.3451. [PMID: 269404]
